Literature DB >> 5662551

Mithramycin treatment of malignant hypercalcaemia.

C R Edwards, G M Besser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5662551      PMCID: PMC1986142          DOI: 10.1136/bmj.3.5611.167

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS.

Authors:  J H BROWN; B J KENNEDY
Journal:  N Engl J Med       Date:  1965-01-21       Impact factor: 91.245

2.  A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.

Authors:  D MATTINGLY
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

3.  Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel.

Authors:  G M Besser; P W Butler; F S Plumpton
Journal:  Br Med J       Date:  1967-11-18

4.  Caution in the use of phosphates in the treatment of severe hypercalcemia.

Authors:  R I Breuer; J LeBauer
Journal:  J Clin Endocrinol Metab       Date:  1967-05       Impact factor: 5.958

5.  Studies of the mechanism by which phosphate infusion lowers serum calcium concentration.

Authors:  L A Hebert; J Lemann; J R Petersen; E J Lennon
Journal:  J Clin Invest       Date:  1966-12       Impact factor: 14.808

6.  Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease.

Authors:  V Parsons; M Baum; M Self
Journal:  Br Med J       Date:  1967-02-25
  6 in total
  4 in total

Review 1.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 2.  Recent progress in calcium metabolism: clinical application.

Authors:  G S Gordan
Journal:  Calif Med       Date:  1971-05

3.  Mithramycin for hypercalcemia of malignant disease.

Authors:  T E Godfrey
Journal:  Calif Med       Date:  1971-10

4.  Mithramycin treatment of hypercalcaemia and renal failure in a patient with paratesticular embryonic sarcoma.

Authors:  V Parsons; G Scott; M Baum; E Molland; J Makin
Journal:  Br J Cancer       Date:  1971-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.